Merck & Co. 1 may 2026 Spotlight On: Merck & Co. maintains BD appetite ahead of $70B sales goal - FirstWord Pharma
Merck & Co. 30 abr 2026 Merck & Co.'s Keytruda posts $8B in Q1 as Qlex picks up steam - FirstWord Pharma
Merck & Co. 30 abr 2026 Merck & Co lifts outlook as Keytruda growth offsets acquisition hit - The Pharma Letter
Merck & Co. 30 abr 2026 Merck's growth products Winrevair, Ohtuvayre trending in opposite directions - Fierce Pharma
Merck & Co. 30 abr 2026 Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones - Yahoo Finance Singapore
Merck & Co. 30 abr 2026 Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones - Yahoo Finance UK
Merck & Co. 30 abr 2026 Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones - Yahoo Finance
Merck & Co. 29 abr 2026 AstraZeneca restarts £300M investment in UK, but Merck not budging - Fierce Biotech
Merck & Co. 27 abr 2026 Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase - Genetic Engineering and Biotechnology News
Merck & Co. 24 abr 2026 Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO - Fierce Pharma